Febrile Clinical Trial
Official title:
A Clinical Data Collection Study of Verily Patch
NCT number | NCT04727801 |
Other study ID # | 102782 |
Secondary ID | |
Status | Terminated |
Phase | |
First received | |
Last updated | |
Start date | March 11, 2021 |
Est. completion date | May 25, 2021 |
Verified date | August 2021 |
Source | Verily Life Sciences LLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a single center, prospective, non-randomized prospective observational data collection study of the Verily Patch. The Verily Patch is an investigational wearable, continuous temperature sensor which will be evaluated against reference oral and axillary temperature measurements to support development activities for the Verily Patch.
Status | Terminated |
Enrollment | 22 |
Est. completion date | May 25, 2021 |
Est. primary completion date | May 25, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - At least 18 years old - Able to read and speak English - Able to read and understand the Informed Consent Form - Willing to wear Verily Patch in the axillary region - Willing to comply with repeated self-measurement of oral and axillary temperatures and willing to record temperature readings - Have a working smartphone device and willing to use it for study activities - Willing to install study apps on their personal smartphone - Willing to comply with all study-related procedures Exclusion Criteria: - Pregnant or breastfeeding during study participation - Have known allergies to medical grade adhesives - Have known cutaneous hypersensitivity - Have infection in both axilla - Have open injury or rash where the study device will be worn - Have a cardiac pacemaker or other implanted electronic medical device(s) - Have any additional condition or situation that, in the opinion of the investigator, makes the subject inappropriate for participation in the study |
Country | Name | City | State |
---|---|---|---|
United States | UT Southwestern Medical Center | Dallas | Texas |
Lead Sponsor | Collaborator |
---|---|
Verily Life Sciences LLC |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Data collection to support development activities for Verily Patch | Data collection to enable device development of the Verily Patch, which includes the development of an algorithm that estimates temperature | Up to 8 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01714570 -
Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia
|
N/A | |
Completed |
NCT00913042 -
Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia
|
N/A | |
Active, not recruiting |
NCT06353490 -
The Clinical Performance Validation of Electronic Thermometer and Infrared Thermometers
|
N/A |